U
PGEN icon

UBS’s Precigen PGEN Stock Holding History

UBS’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$30K Sell
1,674
-7,534
-82% -$154K ﹤0.01% 7477
2014
Q2 		$221K Buy
9,208
+5,441
+144% +$110K ﹤0.01% 5048
2014
Q1 		$95K Buy
+3,767
New +$104K ﹤0.01% 6039
2013
Q4 		– Sell
-105
Closed -$2K – 10664
2013
Q3 		$2K Buy
+105
New +$2.42K ﹤0.01% 9972

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
GTP
Global Thematic Partners New York $120M AUM 25.18% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

UBS's PGEN Position: Q3 2014 in Review

UBS increased its Precigen (PGEN) stake by 356% in Q3 2014, buying an estimated $744K and bringing the position to 46,675 shares worth $829K. The position accounts for ﹤0.01% of the portfolio, ranked #3781.

UBS first reported a position in PGEN in Q3 2013 and has held it in 5 quarters since. The position peaked at $871K in Q4 2013. 102 funds tracked by Wall St. Rank hold PGEN as of Q3 2014.

  • UBS held 46,675 shares of Precigen worth $829K as of Q3 2014.
  • UBS bought 36,446 Precigen shares in Q3 2014, an estimated $744K.
  • Precigen made up ﹤0.01% of UBS's portfolio in Q3 2014, its #3781 holding.
  • UBS first reported a position in Precigen in Q3 2013 and has held it in 5 quarters since.
  • UBS's Precigen position peaked at $871K in Q4 2013.
  • 102 funds tracked by Wall St. Rank held Precigen as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.